mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.
暂无分享,去创建一个
[1] S. Meshnick,et al. Reaction of antimalarial endoperoxides with specific parasite proteins , 1994, Antimicrobial Agents and Chemotherapy.
[2] G. Brittinger,et al. In Acute Myeloid Leukemia only the Coexpression of at Least Two Proteins Including P-Glycoprotein, the Multidrug Resistance-Related Protein MRP, bcl-2, Mutant p53 and Heat-Shock Protein 27 is Predictive for the Response to Induction Chemotherapy , 1998 .
[3] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[4] F. Gay,et al. In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives. , 1994, Bulletin of the World Health Organization.
[5] Y. Tu,et al. The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu. , 1999, Chinese medical journal.
[6] H. J. Woerdenbag,et al. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. , 1993, Journal of natural products.
[7] M. Overman,et al. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. , 2000, International journal of oncology.
[8] T. Efferth,et al. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. , 2002, Blood cells, molecules & diseases.
[9] J. G. Cory,et al. Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents. , 1998, Advances in enzyme regulation.
[10] T. Efferth,et al. The anti-malarial artesunate is also active against cancer. , 2001, International journal of oncology.
[11] D. L. Klayman,et al. Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .
[12] M. Volm,et al. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. , 1992, Anticancer research.
[13] Y. Pommier,et al. Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen. , 1994, Journal of the National Cancer Institute.
[14] T Tanaka,et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. , 2001, Cancer research.
[15] G. Goldenberg,et al. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. , 1988, Cancer research.
[16] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[17] P. Berman,et al. Artemisinin enhances heme-catalysed oxidation of lipid membranes. , 1997, Free radical biology & medicine.
[18] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.